Hush kratom gummies reddit

Hush kratom gummies reddit DEFAULT

Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine

1. Suwanlert S. A study of Kratom eaters in Thailand. Bull Narc. 1975;27(3):21–7. [PubMed]

2. Warner ML, Kaufman NC, Grundmann O. The pharmacology and toxicology of Kratom: from traditional herb to drug of abuse. Int J Legal Med. 2016;130(1):127–38. [PubMed]

3. Jansen K, Prast CJ. Ethnopharmacology of Kratom and the Mitragyna alkaloids. J Ethnopharmacol. 1988;23(1):115–119. [PubMed]

4. Grewal KS. The effect of mitragynine on man. Br J Med Psychol. 2011;12(1):41–58. doi: 10.1111/j.2044-8341.1932.tb01062.x. [CrossRef] [Google Scholar]

5. Matsumoto K, Mizowaki M, Suchitra T, Takayama H, Sakai S-I, Aimi N, et al. Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Life Sci. 1996;59(14):1149–1155. doi: 10.1016/0024-3205(96)00432-8. [PubMed] [CrossRef] [Google Scholar]

6. Kratom (Mitragyna speciosa) Drug Profile. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2015. Accessed 16 Jan 2016.

7. Kratom (Mitragyna speciosa Korth). Drug Enforcement Administration, Office of Diversion Control, Drug & Chemical Evaluation Section. 2013. Accessed 16 Jan 2016.

8. Special Report: Opiates and Related Drugs Reported in NFLIS, 2009–2014. U.S. Department Of Justice, Drug Enforcement Administration, Office of Diversion Control. 2016. Accessed 21 June 2016.

9. Huus K. Asian leaf “kratom” making presence felt in US emergency rooms. NBC News. 2012. Accessed 10 May 2016.

10. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using Kratom (Mitragyna speciosa korth) Addiction. 2008;103(6):1048–1050. doi: 10.1111/j.1360-0443.2008.02209.x.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

11. Prozialeck WC, Jivan JK, Andurkar SV. Pharmacology of Kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc. 2012;112(12):792–799. [PubMed] [Google Scholar]

12. Dargan P, Wood D. Novel Psychoactive Substances. Boston: Academic; 2013.

13. Hassan Z, Muzaimi M, Navaratnam V, Yusoff NHM, Suhaimi FW, Vadivelu R, et al. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev. 2013;37(2):138–151. doi: 10.1016/j.neubiorev.2012.11.012. [PubMed] [CrossRef] [Google Scholar]

14. Cinosi E, Martinotti G, Simonato P, Singh D, Demetrovics Z, Roman-Urrestarazu A, et al. Following “the roots” of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in western countries. Biomed Res Int. 2015;2015:1–11. [PMC free article] [PubMed]

15. Shellard EJ. The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa, Korth. Bull Narc. 1974;26(2):41–55. [PubMed] [Google Scholar]

16. Ponglux D, Wongseripipatana S, Takayama H, Kikuchi M, Kurihara M, Kitajima M, et al. A new indole alkaloid, 7 alpha-hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand. Planta Med. 1994;60(06):580–581. doi: 10.1055/s-2006-959578. [PubMed] [CrossRef] [Google Scholar]

17. Thongpradichote S, Matsumoto K, Tohda M, Takayama H, Aimi N, Sakai S, et al. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life Sci. 1998;62(16):1371–1378. doi: 10.1016/S0024-3205(98)00075-7. [PubMed] [CrossRef] [Google Scholar]

18. Matsumoto K, Mizowaki M, Suchitra T, Murakami Y, Takayama H, Sakai S-I, et al. Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol. 1996;317(1):75–81. doi: 10.1016/S0014-2999(96)00714-5. [PubMed] [CrossRef] [Google Scholar]

19. Gregory TB. Hydromorphone: evolving to meet the challenges of today’s health care environment. Clin Ther. 2013;35(12):2007–2027. doi: 10.1016/j.clinthera.2013.09.027. [PubMed] [CrossRef] [Google Scholar]

20. Matsumoto K, Horie S, Ishikawa H, Takayama H, Aimi N, Ponglux D, et al. Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2004;74(17):2143–2155. doi: 10.1016/j.lfs.2003.09.054. [PubMed] [CrossRef] [Google Scholar]

21. Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D, et al. Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J Med Chem. 2002;45(9):1949–1956. doi: 10.1021/jm010576e. [PubMed] [CrossRef] [Google Scholar]

22. Horie S, Koyama F, Takayama H, Ishikawa H, Aimi N, Ponglux D, et al. Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum. Planta Med. 2005;71(3):231–236. doi: 10.1055/s-2005-837822. [PubMed] [CrossRef] [Google Scholar]

23. Adkins JE, Boyer EW, McCurdy CR. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr Top Med Chem. 2011;11(9):1165–1175. doi: 10.2174/156802611795371305. [PubMed] [CrossRef] [Google Scholar]

24. Roche KM, Hart K, Sangalli B. Kratom: a case of a legal high. Clin Toxicol. 2008;46(7):598.[Google Scholar]

25. McWhirter L, Morris S. A case report of inpatient detoxification after Kratom (Mitragyna speciosa) dependence. Eur Addict Res. 2010;16(4):229–231. doi: 10.1159/000320288. [PubMed] [CrossRef] [Google Scholar]

26. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila) 2008;46(2):146–152. doi: 10.1080/15563650701241795. [PubMed] [CrossRef] [Google Scholar]

27. Matsumoto K, Horie S, Takayama H, Ishikawa H, Aimi N, Ponglux D, et al. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2005;78(1):2–7. doi: 10.1016/j.lfs.2004.10.086. [PubMed] [CrossRef] [Google Scholar]

28. Narita M, Funada M, Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther. 2001;89(1):1–15. doi: 10.1016/S0163-7258(00)00099-1. [PubMed] [CrossRef] [Google Scholar]

29. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996;383(6603):819–823. doi: 10.1038/383819a0. [PubMed] [CrossRef] [Google Scholar]

30. Kikura-Hanajiri R, Kawamura M, Maruyama T, Kitajima M, Takayama H, Goda Y. Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant “Kratom” (Mitragyna speciosa) by LC-ESI-MS. Forensic Toxicol. 2009;27(2):67–74. doi: 10.1007/s11419-009-0070-5. [CrossRef] [Google Scholar]

31. Grewal KS. Observations on the pharmacology of mitragynine. American Society for Pharmacology and Experimental Therapeutics. J Pharmacol Exp Ther. 1932;46(3):251–271.[Google Scholar]

32. Goh TB, Koh RY, Mordi MN, Mansor SM. Antioxidant value and antiproliferative efficacy of mitragynine and a silane reduced analogue. Asian Pac J Cancer Prev. 2014;15(14):5659–5665. doi: 10.7314/APJCP.2014.15.14.5659. [PubMed] [CrossRef] [Google Scholar]

33. Parthasarathy S, Bin Azizi J, Ramanathan S, Ismail S, Sasidharan S, Said MI, et al. Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae Family) leaves. Molecules. Mol Divers Preserv Int. 2009;14(10):3964–3974.[PMC free article] [PubMed] [Google Scholar]

34. Utar Z, Majid MIA, Adenan MI, Jamil MFA, Lan TM. Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264.7 macrophage cells. J Ethnopharmacol. 2011;136(1):75–82. doi: 10.1016/j.jep.2011.04.011. [PubMed] [CrossRef] [Google Scholar]

35. Burkill IH, Haniff M. Malay village medicine, prescriptions collected. Gard Bull. 1930;6:165–321.[Google Scholar]

36. Tanguay P. Kratom in Thailand. Legis Reform Drug Policies. 2011;13:1–16.[Google Scholar]

37. Idayu NF, Hidayat MT, Moklas MAM, Sharida F, Raudzah ARN, Shamima AR, et al. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine. 2011;18(5):402–407. doi: 10.1016/j.phymed.2010.08.011. [PubMed] [CrossRef] [Google Scholar]

38. Harizal SN, Mansor SM, Hasnan J, Tharakan JKJ, Abdullah J. Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent. J Ethnopharmacol. 2010;131(2):404–409. doi: 10.1016/j.jep.2010.07.013. [PubMed] [CrossRef] [Google Scholar]

39. Kumarnsit E, Keawpradub N, Nuankaew W. Effect of Mitragyna speciosa aqueous extract on ethanol withdrawal symptoms in mice. Fitoterapia. 2007;78(3):182–185. doi: 10.1016/j.fitote.2006.11.012. [PubMed] [CrossRef] [Google Scholar]

40. Vicknasingam B, Narayanan S, Beng GT, Mansor SM. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy. 2010;21(4):283–288. doi: 10.1016/j.drugpo.2009.12.003. [PubMed] [CrossRef] [Google Scholar]

41. Ahmad K, Aziz Z. Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. J Ethnopharmacol. 2012;141(1):446–450. doi: 10.1016/j.jep.2012.03.009. [PubMed] [CrossRef] [Google Scholar]

42. Shellard EJ. Ethnopharmacology of Kratom and the Mitragyna alkaloids. J Ethnopharmacol. 1989;25(1):123–124. doi: 10.1016/0378-8741(89)90053-6. [PubMed] [CrossRef] [Google Scholar]

43. Erowid. Kratom Dosage. The Vaults of Erowid. 2015. Accessed 23 Jan 2016.

44. Erowid. Kratom (Mitragyna speciosa) Effects. The Vaults of Erowid. 2016. Accessed 23 Jan 2016.

45. Thuan LC. Addiction to Mitragyna speciosa. Proc Alumni Assoc. 1957;10:322–324.[Google Scholar]

46. Yusoff NHM, Suhaimi FW, Vadivelu RK, Hassan Z, Rümler A, Rotter A, et al. Abuse potential and adverse cognitive effects of mitragynine (Kratom. Addict Biol. 2014;21:98–110. doi: 10.1111/adb.12185. [PubMed] [CrossRef] [Google Scholar]

47. Nelsen JL, Lapoint J, Hodgman MJ, Aldous KM. Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure. J Med Toxicol. 2010;6(4):424–426. doi: 10.1007/s13181-010-0079-5.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

48. Lu J, Wei H, Wu J, Jamil MFA, Tan ML, Adenan MI, et al. Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes. Clin Toxicol. 2014;9(12):e115648.[PMC free article] [PubMed] [Google Scholar]

49. Cabellon M, Aris R, Pathak V. Adult respiratory distress syndrome secondary to the use of herbal drug kratom. Am J Respir Crit Care Med. 2014;189:A6492.[Google Scholar]

50. Sheleg SV, Collins GB. A coincidence of addiction to “Kratom” and severe primary hypothyroidism. J Addict Med. 2011;5(4):300–301. doi: 10.1097/ADM.0b013e318221fbfa. [PubMed] [CrossRef] [Google Scholar]

51. Kapp FG, Maurer HH, Auwärter V, Winkelmann M, Hermanns-Clausen M. Intrahepatic cholestasis following abuse of powdered Kratom (Mitragyna speciosa) J Med Toxicol. 2011;7(3):227–231. doi: 10.1007/s13181-011-0155-5.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

52. Lu J, Wei H, Wu J, Jamil M, Tan ML, Adenan MI. Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes. PLoS One. 2014;9(12):e115648. doi: 10.1371/journal.pone.0115648.[PMC free article] [PubMed] [CrossRef] [Google Scholar]

53. Holler JM, Vorce SP, McDonough-Bender PC, Joseph Magluilo J, Solomon CJ, Levine B. A drug toxicity death involving propylhexedrine and mitragynine. J Anal Toxicol. 2011;35(1):54–59. doi: 10.1093/anatox/35.1.54. [PubMed] [CrossRef] [Google Scholar]

54. Tungtananuwat W, Lawanprasert S. Fatal 4×100: homemade Kratom juice cocktail. J Health Res. 2010;24(1):43–47.[Google Scholar]

55. Neerman MF, Frost RE, Deking J. A drug fatality involving Kratom. J Forensic Sci. 2013;58(s1):S278–S279. doi: 10.1111/1556-4029.12009. [PubMed] [CrossRef] [Google Scholar]

56. McIntyre IM, Trochta A, Stolberg S, Campman SC. Mitragynine “Kratom” related fatality: a case report with postmortem concentrations. J Anal Toxicol. 2015;39(2):152–155. doi: 10.1093/jat/bku137. [PubMed] [CrossRef] [Google Scholar]

57. Kronstrand R, Roman M, Thelander G, Eriksson A. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton. J Anal Toxicol. 2011;35(4):242–247. doi: 10.1093/anatox/35.4.242. [PubMed] [CrossRef] [Google Scholar]

58. Scott TM, Yeakel JK, Logan BK. Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online. Drug Test Anal. 2014;6(9):959–963. doi: 10.1002/dta.1673. [PubMed] [CrossRef] [Google Scholar]

59. Dietary Supplement Health and Education Act of 1994. National Institutes of Health Office of Dietary Supplements. 1994. Accessed 31 Jan 2016.

60. Petróczi A, Ocampo JAV, Shah I, Jenkinson C, New R, James RA, et al. Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users. Subst Abuse Treat Prev Policy. 2015;10(1). [PMC free article] [PubMed]

61. Rebiere H, Guinot P, Civade C, Bonnet P-A, Nicolas A. Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(2):161–171. doi: 10.1080/19440049.2011.638676. [PubMed] [CrossRef] [Google Scholar]

62. Venhuis BJ, Zwaagstra ME, Van den Berg J. Trends in drug substances detected in illegal weight-loss medicines and dietary supplements. RIVM Report. 2009;370030002:1–37.

63. Jung J, Hermanns-Clausen M, Weinmann W. Anorectic sibutramine detected in a Chinese herbal drug for weight loss. Forensic Sci Int. 2006;161(2–3):221–222. doi: 10.1016/j.forsciint.2006.02.052. [PubMed] [CrossRef] [Google Scholar]

64. Wang J, Chen B, Yao S. Analysis of six synthetic adulterants in herbal weight-reducing dietary supplements by LC electrospray ionization-MS. Food Addit Contam. 2008;25(7):822–830. doi: 10.1080/02652030801946553. [PubMed] [CrossRef] [Google Scholar]

65. Vaysse J, Balayssac S, Gilard V, Desoubdzanne D, Malet-Martino M, Martino R. Analysis of adulterated herbal medicines and dietary supplements marketed for weight loss by DOSY 1H-NMR. Food Addit Contam. 2010;27(7):903–916. doi: 10.1080/19440041003705821. [PubMed] [CrossRef] [Google Scholar]

66. Shi Y, Sun C, Gao B, Sun A. Development of a liquid chromatography tandem mass spectrometry method for simultaneous determination of eight adulterants in slimming functional foods. J Chromatogr A. 2011;1218(42):7655–7662. doi: 10.1016/j.chroma.2011.08.038. [PubMed] [CrossRef] [Google Scholar]

67. De Carvalho LM, Cohen PA, Silva CV, Moreira APL, Falcão TM, Molin TRD, et al. A new approach to determining pharmacologic adulteration of herbal weight loss products. Food Addit Contam: Part A. 2012;29(11):1661–1667. doi: 10.1080/19440049.2012.706834. [PubMed] [CrossRef] [Google Scholar]

68. Park S-R, Lee JG, Roh SH, Kim G, Kwon CH, Park HR, et al. Determination of PDE-5 inhibitors and appetite suppressants in adulterated dietary supplements using LC/PDA and LC/MS. Food Addit Contam: Part B. 2012;5(1):29–32. doi: 10.1080/19393210.2012.656706. [PubMed] [CrossRef] [Google Scholar]

69. Song F, Monroe D, El-Demerdash A, Palmer C. Screening for multiple weight loss and related drugs in dietary supplement materials by flow injection tandem mass spectrometry and their confirmation by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2014;88:136–143. doi: 10.1016/j.jpba.2013.08.031. [PubMed] [CrossRef] [Google Scholar]

70. Kim HJ, Lee JH, Park HJ, Cho S-H, Cho S, Kim WS. Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS/MS. Food Addit Contam: Part A. 2014;31(5):777–783. doi: 10.1080/19440049.2014.888497. [PubMed] [CrossRef] [Google Scholar]

71. Hachem R, Malet-Martino M, Gilard V. First identification and quantification of lorcaserin in an herbal slimming dietary supplement. J Pharm Biomed Anal. 2014;98:94–99. doi: 10.1016/j.jpba.2014.05.003. [PubMed] [CrossRef] [Google Scholar]

72. Reeuwijk NM, Venhuis BJ, de Kaste D, Hoogenboom RLAP, Rietjens IMCM, Martena MJ. Active pharmaceutical ingredients detected in herbal food supplements for weight loss sampled on the Dutch market. Food Addit Contam: Part A. 2014;31(11):1783–1793. doi: 10.1080/19440049.2014.958574. [PubMed] [CrossRef] [Google Scholar]

73. Mathon C, Ankli A, Reich E, Bieri S, Christen P. Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry. Food Addit Contam: Part A. 2013;31(1):15–20. doi: 10.1080/19440049.2013.861934. [PubMed] [CrossRef] [Google Scholar]

74. Strano-Rossi S, Odoardi S, Castrignanò E, Serpelloni G, Chiarotti M. Liquid chromatography–high resolution mass spectrometry (LC–HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplements. J Pharm Biomed Anal. 2015;106:144–152. doi: 10.1016/j.jpba.2014.06.011. [PubMed] [CrossRef] [Google Scholar]

75. Maughan RJ. Contamination of dietary supplements and positive drug tests in sport. J Sports Sci. 2005;23(9):883–889. doi: 10.1080/02640410400023258. [PubMed] [CrossRef] [Google Scholar]

76. Maughan RJ, Greenhaff PL, Hespel P. Dietary supplements for athletes: emerging trends and recurring themes. J Sports Sci. 2011;29(suppl 1):S57–S66. doi: 10.1080/02640414.2011.587446. [PubMed] [CrossRef] [Google Scholar]

77. Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W. Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids—results of an international study. Int J Sports Med. 2004;25(2):124–129. doi: 10.1055/s-2004-819955. [PubMed] [CrossRef] [Google Scholar]

78. Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 2008;43(7):892–902. doi: 10.1002/jms.1452. [PubMed] [CrossRef] [Google Scholar]

79. van der Merwe PJ, Grobbelaar E. Unintentional doping through the use of contaminated nutritional supplements. S Afr Med J. 2005;95(7):510–511. [PubMed] [Google Scholar]

80. Pipe A, Ayotte C. Nutritional supplements and doping. Clin J Sport Med. 2002;12(4):245–249. doi: 10.1097/00042752-200207000-00008. [PubMed] [CrossRef] [Google Scholar]

81. Campbell N, Clark JP, Stecher VJ, Thomas JW, Callanan AC, Donnelly BF, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med. 2013;10(7):1842–1849. doi: 10.1111/jsm.12172. [PubMed] [CrossRef] [Google Scholar]

82. Gratz SR, Flurer CL, Wolnik KA. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC–ESI–MS and LC–UV. J Pharm Biomed Anal. 2004;36(3):525–533. doi: 10.1016/j.jpba.2004.07.004. [PubMed] [CrossRef] [Google Scholar]

83. Ng CS, Law TY, Cheung YK, Ng PC, Choi KK. Development of a screening method for the detection of analogues of sildenafil and vardenafil by the use of liquid chromatograph coupled with triple quadrupole linear ion trap mass spectrometer. analytical methods. Royal Soc Chem. 2010;2(7):890–896.[Google Scholar]

84. Savaliya AA, Shah RP, Prasad B, Singh S. Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC–MS/TOF. J Pharm Biomed Anal. 2010;52(3):406–409. doi: 10.1016/j.jpba.2009.05.021. [PubMed] [CrossRef] [Google Scholar]

85. Zhang Y, Huang Z, Ding L, Yan H, Wang M, Zhu S. Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry. J Sep Sci. 2010;33(14):2109–14. doi: 10.1002/jssc.200900841. [PubMed] [CrossRef] [Google Scholar]

86. Toomey VM, Litzau JJ, Flurer CL. Isolation and structural characterization of two tadalafil analogs found in dietary supplements. J Pharm Biomed Anal. 2012;59:50–57. doi: 10.1016/j.jpba.2011.09.038. [PubMed] [CrossRef] [Google Scholar]

87. Ren Y, Wu C, Zhang J. Simultaneous screening and determination of 18 illegal adulterants in herbal medicines and health foods for male sexual potency by ultra-fast liquid chromatography-electrospray ionization tandem mass spectrometry. J Sep Sci. 2012;35(21):2847–2857. doi: 10.1002/jssc.201200280. [PubMed] [CrossRef] [Google Scholar]

88. Vaysse J, Gilard V, Balayssac S, Zedde C, Martino R, Malet-Martino M. Identification of a novel sildenafil analogue in an adulterated herbal supplement. J Pharm Biomed Anal. 2012;59:58–66. doi: 10.1016/j.jpba.2011.10.001. [PubMed] [CrossRef] [Google Scholar]

89. Jankovics P, Lohner S, Darcsi A, Németh-Palotás J, Béni S. Detection and structure elucidation of hydroxythiovardenafil as an adulterant in a herbal dietary supplement. J Pharm Biomed Anal. 2013;74:83–91. doi: 10.1016/j.jpba.2012.10.013. [PubMed] [CrossRef] [Google Scholar]

90. Lee E-S, Kim JW, Lee JH, Han KM, Cho S, Hwang I, et al. Identification of a new tadalafil analogue found in a dietary supplement. Food Addit Contam: Part A. 2013;30(4):621–626. doi: 10.1080/19440049.2013.766766. [PubMed] [CrossRef] [Google Scholar]

91. Lee E-S, Lee JH, Han KM, Kim JW, Hwang IS, Cho S, et al. Simultaneous determination of 38 phosphodiesterase-5 inhibitors in illicit erectile dysfunction products by liquid chromatography–electrospray ionization-tandem mass spectrometry. J Pharm Biomed Anal. 2013;83:171–178. doi: 10.1016/j.jpba.2013.05.009. [PubMed] [CrossRef] [Google Scholar]

92. Lebel P, Gagnon J, Furtos A, Waldron KC. A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products. J Chromatogr A. 2014;1343:143–151. doi: 10.1016/j.chroma.2014.03.078. [PubMed] [CrossRef] [Google Scholar]

93. Damiano F, Silva C, Gregori A, Vacondio F, Mor M, Menozzi M, et al. Analysis of illicit dietary supplements sold in the Italian market: identification of a sildenafil thioderivative as adulterant using UPLC–TOF/MS and GC/MS. Sci Justice. 2014;54(3):228–237. doi: 10.1016/j.scijus.2014.02.009. [PubMed] [CrossRef] [Google Scholar]

94. Thailand Narcotics Control Division. Table of controlled narcotic drugs in Thailand. 2015. Accessed 10 May 2016.

95. Adulyadej B. Narcotics Act. Thailand Narcotics Control Division. 1979. Accessed 10 May 2016.

96. House Enrolled Act No. 1196. In: Second Regular Session 117th General Assembly. 2012. Accessed 10 May 2016.

97. Beavers M. Senate Bill 48. General Assembly of the State of Tennessee. 2013. Accessed 10 May 2016.

98. Vermont Department of Health. Regulated Drug Rule. 2016. Accessed 10 May 2016.

99. Louisiana State Legislature. RS 40:989.3. 2012. Accessed 10 May 2016.

100. Uniform Controlled Substances Act. Wisconsin State Legislature. 2016. Accessed 10 May 2016.

101. House File 2355 [Internet]. [cited 2016 May 10]. Available from:

102. Kratom Control Act. Illinois General Assembly. 2015. Accessed 10 May 2016.

103. U.S. Food and Drug Administration. Import Alert 54–15. 2016. Accessed 10 May 2016.

104. U.S. Food and Drug Administration. New Dietary Ingredients Notification Process. 2016. Accessed 10 May 2016.

105. United States Government Publishing Office. 21- Food and Drugs §§ 342. Accessed 19 May 2016.

106. U.S. Food and Drug Administration. US Marshals Seize Dietary Supplements Containing Kratom. 2016. Accessed 10 May 2016.

107. U.S. Department of Justice Drug Enforcement Administration. Drugs of Abuse. 2015. Accessed 10 May 2016.

108. Yoburn BC, Shah S, Chan K, Duttaroy A, Davis T. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity. Pharmacol Biochem Behav. 1995;51(2–3):535–539. doi: 10.1016/0091-3057(94)00375-S. [PubMed] [CrossRef] [Google Scholar]


Hush Kratom Gummies Experience Report

Today I will be eating a Kratom edible for the first time in my life. Specifically, I will be taking Hush Kratom Gummies, which are infused with Kratom extract.

Apparently these gummies are ‘Tropical Passion’ flavored, and each gummy contains 10-11 mg of Mitragynine, but it is a full spectrum extract so it contains a bit of 7-hydroxymitragynine as well. Since a gram of Kratom leaf typically has 10-15 mg of Mitragynine, each gummy is like taking a gram of Kratom leaf. This is especially true when considering that Kratom extract works stronger and faster than Kratom leaf, so a dose of 10-11 mg of extract per gummy could actually have stronger effects than a gram of Kratom.

Further, this pack has 10 gummies in it, so if I eat the whole pack it will certainly be a powerful dose of Kratom. That being said, I’m planning on sharing a little of it with my wife.

Notably, I have not taken any Kratom since yesterday, so these Kratom gummies should work to their full potential. Also, my stomach is empty, so it should work more efficiently.

Without further ado, here is the experience report!

11:44 AM I open the bag and it smells like really strong pineapple. Each gummy is in the shape of a little star, here is the picture below.

11:48 AM I finally eat one of the gummies. It’s a bit chewy for a gummy, and is quite bitter for candy, and in-fact I can taste the Kratom in it a bit. That being said, it is quite palatable and tastes really good for a Kratom-based product. The pineapple really seems to equalize the Kratom taste.

11:51 AM Not even done eating the gummies and I feel a surge of opioid warmth.

11:52 AM I finish eating the gummies, and by the time I got to the last couple of them I am really loving the taste. It’s a very unique taste of tropical fruit with a slight note of Kratom.

I took 8 gummies total, which is 80-88 mg of Mitragynine, equivalent to 5-9 grams of leaf. I gave two to my wife.

11:55 AM Unmistakable feeling of building euphoria and stress relief. These gummies are surprisingly potent.

11:59 AM Feeling really sedated suddenly, which happens sometimes when I take Kratom after not getting enough sleep.

12:55 PM Well the sedation got stronger and stronger, and I was somewhere between a dream and reality while laying in bed, with strong euphoria and opioid analgesia. These gummies have way exceeded my expectations!

Now that I’m up feeling very relaxed and euphoric, zero aches and pains, and zero stress.

1:35 PM Incredibly talkative, articulate, and energetic, while simultaneously extremely relaxed and euphoric. It’s amazing how this experience has transitioned from a strong sedative effect to highly energetic.

2:28 PM Ate lunch, still feeling strongly relaxing effects.

Overall, I give these Hush Kratom extract gummies an A+. They far exceeded my expectations, and brought about an extremely powerful Kratom experience even though I did not even take the whole bag. Also, it is a much nicer way to take Kratom than powder or capsules. Based on this, I think Kratom edibles have a bright future, and I hope more varieties of edibles start to hit the market in the coming years.

  1. Beveled edge bathroom mirror
  2. Anime twitch overlays
  3. 2000 cavalier for sale
  4. Ups alps
  5. Altiumdesigner 10

What is Kratom?

Kratom is also known as Mitragyna Speciosa. Kratom is a tropical tree with a long history of conventional use in parts of Africa and Southeast Asia. Kratom is otherwise called Thom, Thang, and Biak. Its leaves and the teas prepared from them have for some time been utilized by individuals in that area. Kratom is really devoured all through the world for certain impacts (in the type of Tea, chewed, or ingested in capsules). The unique plant has been around this world for quite some time now. However, most people had never even heard of Kratom nor the origin of Kratom until as of recently, within the past couple of years.

Consumers all over the world now desire and have a strong appetite for this plant, as some of its effects have been recorded and well-documented to the public. However, there are effects and parts of this plant that are still unknown to the public. Till today, the plant doesn’t have much proper research conducted on it, so its efficacy is still not fully verified. However, scientists and curious people alike are working to change that and record any official effects.

Where did Kratom come from though? The origin of Kratom is not completely known. Only assumptions can be made from bits and pieces found within the recorded history of this plant. We know so far that the Kratom plant originates from Southeast Asia. It has been used within that area by native cultures for a variety of purposes, for many centuries. For example, tribal societies had used it in the past as a mild stimulant by chewing on its leaves, as it was very similar to Khat or Coca in a functional sense.

We also strive to remind people to always be careful with the amount of Kratom being consumed.

Be sure to browse all our kratom, kava, and other types of products. We have a variety of kratom products!

Why Choose NuWave Botanical for Kratom?

NuWave Botanicals sells only the best, high-quality kratom capsules and products. Our process is trusted by all of our users and our customer experience is one of the best. Here at NuWave Botanicals, we understand how important it is to have a good buying experience. Our community would love to have you join in to research how we do things and even share our story with you, as well as sharing our botanicals.

We have many reasons why you should purchase your kratom capsules from NuWave Botanicals. The cleanliness of our kratom products, as well as other products, is second to none. We also only sell only high-quality kratom, which comes straight from the cleanest of gardens within Indonesia. With our business, we contribute and assist businesses in Indonesia, which overall helps the country's economy in a variety of ways. Our facility is a constant clean environment, to ensure that none of our products are ever contaminated or unclean. Our facility also handles and packages all our kratom products carefully, so that our products come to your in perfect condition. In addition to our packaging, we ensure that our products are shipped directly to you from our facility.

NuWave Botanicals has some of the newest kratom products on the market. We make sure that we are able to provide these products to our consumers at the lowest possible prices. Our high-quality products are put together through professional practices to ensure that the product still holds an amazing taste. We also hold constant sales for many of our kratom products, no matter what type it is.

Our Customer Service

On the off chance that you have any inquiries or concerns, if it's not too much trouble contact our help. We are here to help. Got a question or concern for our customer service? Converse with a genuine person.

You're not going to hang tight for days for a simple solution to your message or need to look out for hold when you call us. At NuWave Botanicals, we give amazing customer assistance — a similar kind that we'd want to encounter ourselves.

We work in an industry based on trust. This is accomplished through correspondence and experienced help. We invest heavily in addressing all help inquiries as soon as possible.

Your satisfaction is extremely important to us and we need you to have the most ideal involvement in us. We esteem all input — both positive and negative — and use it to improve the items we offer and to construct more grounded associations with our clients. In the event that you might want to impart a positive encounter to us, it would be ideal if you leave an audit. In the event that you've experienced an issue or you're not happy with our administration, it would be ideal if you contact our client care group utilizing one of the contact strategies recorded previously. We plan to determine all protests so you are content with the result.

FDA’s Disclosure

There are no FDA-approved uses for kratom, and the agency has received concerning reports about the safety of kratom. FDA is actively evaluating all available scientific information on this issue and continues to warn consumers not to use any products labeled as containing the botanical substance kratom or its psychoactive compounds, mitragynine and 7-hydroxymitragynine. FDA encourages more research to better understand kratom’s safety profile, including the use of kratom combined with other drugs.

While FDA evaluates the available safety information about the effects of kratom, the agency encourages health care professionals and consumers to report any adverse reactions to the FDA’s MedWatch program.



Joe Rogan - Kratom Gets You High!!


Reddit hush kratom gummies


BEWARE - 3 Things NOT to Do While Using Kratom


Similar news:


568 569 570 571 572